| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/23/2023 | 30.43% | UBS | $4.7 → $7.5 | Upgrades | Neutral → Buy |
| 08/09/2023 | 4.35% | Piper Sandler | $5 → $6 | Maintains | Overweight |
| 06/12/2023 | -13.04% | Credit Suisse | $6.5 → $5 | Downgrades | Outperform → Neutral |
| 06/02/2023 | -13.04% | Piper Sandler | → $5 | Reiterates | Overweight → Overweight |
| 05/11/2023 | -13.04% | Piper Sandler | → $5 | Reiterates | → Overweight |
| 05/10/2023 | 4.35% | Itau BBA | → $6 | Upgrades | Market Perform → Outperform |
| 03/09/2023 | -13.04% | DA Davidson | → $5 | Initiates Coverage On | → Buy |
| 03/03/2023 | -13.04% | Piper Sandler | → $5 | Reiterates | → Overweight |
| 12/20/2022 | -13.04% | Piper Sandler | $6 → $5 | Maintains | Overweight |
| 12/19/2022 | -13.04% | Morgan Stanley | $7 → $5 | Downgrades | Overweight → Equal-Weight |
| 10/20/2022 | -25.22% | UBS | → $4.3 | Initiates Coverage On | → Neutral |
| 08/26/2022 | 13.04% | B of A Securities | $4.5 → $6.5 | Upgrades | Neutral → Buy |
| 07/22/2022 | 4.35% | Piper Sandler | $9 → $6 | Maintains | Overweight |
| 07/07/2022 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 07/05/2022 | 4.35% | Goldman Sachs | $12 → $6 | Maintains | Buy |
| 05/13/2022 | 56.52% | Piper Sandler | $11 → $9 | Maintains | Overweight |
| 05/13/2022 | 39.13% | Keybanc | $10 → $8 | Maintains | Overweight |
| 04/29/2022 | 39.13% | Credit Suisse | $10 → $8 | Upgrades | Neutral → Outperform |
| 04/25/2022 | 91.3% | Piper Sandler | $13 → $11 | Maintains | Overweight |
| 02/14/2022 | 73.91% | Credit Suisse | → $10 | Initiates Coverage On | → Neutral |
| 01/25/2022 | 73.91% | Keybanc | $25 → $10 | Maintains | Overweight |
| 01/19/2022 | 178.26% | Goldman Sachs | $26 → $16 | Maintains | Buy |
| 01/18/2022 | 178.26% | Goldman Sachs | $26 → $16 | Upgrades | Neutral → Buy |
| 01/18/2022 | 126.09% | Piper Sandler | → $13 | Initiates Coverage On | → Overweight |
| 10/21/2021 | 421.74% | Keybanc | $35 → $30 | Maintains | Overweight |
| 09/24/2021 | 421.74% | Morgan Stanley | → $30 | Upgrades | Equal-Weight → Overweight |
| 08/16/2021 | 334.78% | Goldman Sachs | → $25 | Initiates Coverage On | → Neutral |
| 08/16/2021 | 519.13% | Itau BBA | → $35.6 | Initiates Coverage On | → Outperform |
| 08/16/2021 | 508.7% | JP Morgan | → $35 | Initiates Coverage On | → Neutral |
| 08/16/2021 | 508.7% | Keybanc | → $35 | Initiates Coverage On | → Overweight |
What is the target price for Vtex (VTEX)?
The latest price target for Vtex (NYSE: VTEX) was reported by UBS on August 23, 2023. The analyst firm set a price target for $7.50 expecting VTEX to rise to within 12 months (a possible 30.43% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Vtex (VTEX)?
The latest analyst rating for Vtex (NYSE: VTEX) was provided by UBS, and Vtex upgraded their buy rating.
When is the next analyst rating going to be posted or updated for Vtex (VTEX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vtex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vtex was filed on August 23, 2023 so you should expect the next rating to be made available sometime around August 23, 2024.
Is the Analyst Rating Vtex (VTEX) correct?
While ratings are subjective and will change, the latest Vtex (VTEX) rating was a upgraded with a price target of $4.70 to $7.50. The current price Vtex (VTEX) is trading at is $5.75, which is within the analyst's predicted range.